Search research articles
Contact Us
Filters
Showing results (41-50 of 171) with videos related to
Page
of 18
Sort By:
The Journal of Rheumatology
|
June 18, 2002
Cutaneous T cell lymphoma in a patient with primary biliary cirrhosis and secondary Sjögren's syndrome
Arne Stroehmann, Thomas Dörner, Ansgar Lukowsky, et al.
The Journal of Rheumatology
|
July 27, 2005
New glucocorticoids on the horizon: repress, don't activate!
In-Ho Song, Ralf Gold, Rainer H Straub, et al.
The Journal of Rheumatology
|
July 5, 2005
New Glucocorticoids on the Horizon: Repress, Don't Activate!
In-Ho Song, Ralf Gold, Rainer H Straub, et al.
Der Internist
|
December 8, 2021
[What is confirmed in the treatment of autoinflammatory fever diseases?]
Anne Pankow, Eugen Feist, Ulrich Baumann, et al.
Deutsches Arzteblatt International
|
June 15, 2017
The Diagnosis and Treatment of Sjögren's Syndrome
Ana-Luisa Stefanski, Christian Tomiak, Uwe Pleyer, et al.
BMC Rheumatology
|
December 28, 2021
Macrophage activation syndrome in a patient with adult-onset Still's disease following first COVID-19 vaccination with BNT162b2
Frédéric Muench, Martin Krusche, Leif Erik Sander, et al.
Arthritis Research & Therapy
|
March 16, 2018
Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity
Christian Schwedler, Thomas Häupl, Ulrich Kalus, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 27, 2022
SIGLEC-1 in Systemic Sclerosis: A Useful Biomarker for Differential Diagnosis
Jakob Höppner, Vincent Casteleyn, Robert Biesen, et al.
Thrombosis Research
|
May 15, 2020
Fibrinogen, factor XIII and α<sub>2</sub>-antiplasmin genotypes are associated with inflammatory activity and anti-citrullinated protein antibodies
Berthold Hoppe, Christian Schwedler, Anke Edelmann, et al.
Annals of the Rheumatic Diseases
|
December 3, 2013
Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
Joachim Listing, Jörn Kekow, Bernhard Manger, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 171) with videos related to
Sort By:
Page
of 18
The Journal of Rheumatology
|
June 18, 2002
Cutaneous T cell lymphoma in a patient with primary biliary cirrhosis and secondary Sjögren's syndrome
Arne Stroehmann, Thomas Dörner, Ansgar Lukowsky, et al.
The Journal of Rheumatology
|
July 27, 2005
New glucocorticoids on the horizon: repress, don't activate!
In-Ho Song, Ralf Gold, Rainer H Straub, et al.
The Journal of Rheumatology
|
July 5, 2005
New Glucocorticoids on the Horizon: Repress, Don't Activate!
In-Ho Song, Ralf Gold, Rainer H Straub, et al.
Der Internist
|
December 8, 2021
[What is confirmed in the treatment of autoinflammatory fever diseases?]
Anne Pankow, Eugen Feist, Ulrich Baumann, et al.
Deutsches Arzteblatt International
|
June 15, 2017
The Diagnosis and Treatment of Sjögren's Syndrome
Ana-Luisa Stefanski, Christian Tomiak, Uwe Pleyer, et al.
BMC Rheumatology
|
December 28, 2021
Macrophage activation syndrome in a patient with adult-onset Still's disease following first COVID-19 vaccination with BNT162b2
Frédéric Muench, Martin Krusche, Leif Erik Sander, et al.
Arthritis Research & Therapy
|
March 16, 2018
Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity
Christian Schwedler, Thomas Häupl, Ulrich Kalus, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 27, 2022
SIGLEC-1 in Systemic Sclerosis: A Useful Biomarker for Differential Diagnosis
Jakob Höppner, Vincent Casteleyn, Robert Biesen, et al.
Thrombosis Research
|
May 15, 2020
Fibrinogen, factor XIII and α<sub>2</sub>-antiplasmin genotypes are associated with inflammatory activity and anti-citrullinated protein antibodies
Berthold Hoppe, Christian Schwedler, Anke Edelmann, et al.
Annals of the Rheumatic Diseases
|
December 3, 2013
Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
Joachim Listing, Jörn Kekow, Bernhard Manger, et al.
Page
of 18